The Sterile Auto-Disable syringes with/without needle for single use is used for aspiration of fluids from vials and ampoules and a variety of fluid injections below the surface of the skin except phlebotomy.

Device Description

The Sterile Auto-Disable syringes with/without needle for single use is a syringe with or without needle, sterile, single use hypodermic syringe with a 6% (Luer) male connector/lock fitting in various sizes. The syringe assembly consists of a lubricated polypropylene barrel with a graduated scale, a lubricated synthetic rubber stopper and a polypropylene plunger rod. The plunger rod is pulled back to aspirate fluids or depressed to inject or expel fluids. The main principle of the syringe is that after the injection is completed, the device automatically locks the plunger to prevent reuse.

AI/ML Overview

The provided document is a 510(k) summary for a medical device (Sterile Auto-Disable Syringes with/without Needle for Single Use). It describes the device, its intended use, and compares it to a predicate device to establish substantial equivalence. However, the document does not contain the specific details about acceptance criteria and the comprehensive study results to prove that the device meets those criteria, as requested in your prompt regarding a typical device performance study.

The prompt asks for details like:

A table of acceptance criteria and the reported device performance: This is not provided in a summarized table format for specific performance metrics.
Sample sizes used for the test set and the data provenance: Not specified for each test.
Number of experts used to establish the ground truth... and their qualifications: Not applicable as this is a physical medical device, not an AI/diagnostic software.
Adjudication method: Not applicable.
Multi-reader multi-case (MRMC) comparative effectiveness study: Not applicable.
Standalone performance: The document describes performance testing for the device itself (standalone in a physical sense), but not algorithm standalone performance.
Type of ground truth used: For physical device testing, ground truth refers to established standard measurements and specifications (e.g., ISO standards).
Sample size for the training set: Not applicable (not an AI/ML device).
How the ground truth for the training set was established: Not applicable.

What the document does provide regarding performance and testing:

The Section "VII Performance Testing" lists the types of tests conducted:

Biocompatibility testing:
- Classification: Externally Communicating Device, Blood Path Indirect, Limited Contact (<24 hours).
- Tests conducted: Cytotoxicity, Skin Sensitization, Intracutaneous Reactivity (Irritation), Acute Systemic Toxicity, Material-Mediated Pyrogens, Hemolysis, Particulate Matter per USP <788>.
- Acceptance Criteria/Reported Performance: It states "Conforms to ISO 10993" and "Non-pyrogenic" but does not provide specific numerical outcomes or detailed acceptance criteria for each sub-test.
Sterilization, Shipping and shelf-life:
- Tests conducted: EO sterilization validation per ISO11135:2014, Pyrogen testing per USP <85>, EO residuals per ISO 10993-7, Simulated shipping per ASTM D4169, Sterile Barrier Package testing (Seal Strength ASTM F88/F88M-2015, Bubble leak testing ASTM D3078-02(2013), Dye Penetration ASTM F1929-2015).
- Acceptance Criteria/Reported Performance: "Shelf life of 5 years validated using FDA recognized standards ASTM F1980-16." It implies compliance with these standards, but doesn't offer specific data points or "acceptance criteria met" statements for each.
Performance testing:
- Tests conducted according to: ISO 7864:2016, ISO 9626:2016, ISO 80369-7:2016, ISO 7886-4:2018, ISO 7886-1:2017.
- Acceptance Criteria/Reported Performance: The comparison table (Table 5-1) under "Performance specifications" states: "Complies with ISO 7864, ISO 7886-1, ISO 7886-4." This indicates the device passed these standards, which inherently include acceptance criteria for parameters like syringe dimensions, fluid leakage, plunger force, auto-disable features, etc. However, the exact specific criteria and the numerical results are not detailed in this summary.

In summary, based only on the provided text, I cannot construct the detailed table and answer all points of your prompt because the 510(k) summary provides a high-level overview of the types of tests performed and the standards met, rather than detailed acceptance criteria and specific reported performance metrics for each test. The document confirms that testing was done to demonstrate compliance with relevant international standards, which is typical for a 510(k) submission showing substantial equivalence for a physical device.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: on the left, there is a symbol representing the Department of Health & Human Services, and on the right, there is the text "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue. The FDA logo is a recognizable symbol of the agency responsible for regulating food and drug products in the United States.

February 15, 2022

Zhejiang Kangkang Medical-Devices CO., Ltd. Chun Guo Quality Manager Longwang Industrial District, Chumen Town Yuhuan. Zhejiang 317605 China

Re: K210229

Trade/Device Name: Sterile Auto-Disable Syringes with/without Needle for Single Use Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: Class II Product Code: FMF, FMF, FMI Dated: January 7, 2022 Received: January 12, 2022

Dear Chun Guo:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

CAPT Alan M. Stevens Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K210229

Device Name

Sterile Auto-Disable syringes with/without needle for single use

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
-------------------------------------------------	--

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

K210229 510(k) summary

February 15, 2022

l Submitter

Device submitter: Zhejiang Kangkang Medical-Devices CO., Ltd. Longwang Industrial District, Chumen Town, Yuhuan, Zhejiang, 317605. China

Contact person: Chun Guo General Manager Phone: 13586180908 / 89902728 Fax: 0576-87427630 Email: guochun@vip.126.com

II Device

Trade Name of Device: Sterile Auto-Disable syringes with/without needle for single use Common Name: Piston Syringe Regulation Number: 21 CFR 880.5860 21 CFR 880.5570 Regulation Name: Piston Syringe Regulatory Class: II Product code: FMF, FMF, FMI Review Panel: General Hospital

III Predicate Devices

Trade name:	Safety Auto-Disable Syringe with Needle (Auto-Lock)
Common name:	Piston Syringe
Classification:	Class II, 21 CFR 880.5860
Product Code:	MEG, FMF, FMI
Premarket Notification:	K143497
Manufacturer:	Guangdong Intmed Medical Appliance Co., Ltd.

IV Device description

{4}------------------------------------------------

Syringe Size	Needle Gauge	Needle Length
Available in 1ml, 3ml, 5mland 10ml.	Available in 18G, 19G, 20G,21G, 22G, 23G, 24G, 25G,26G, 27G, 30G	Available in 1/2", 5/8", 1",1 1/4", 1 1/2"

V Indications for use

VI Comparison of technological characteristics with the predicate devices

The Sterile Auto-Disable syringes with/without needle for single use have the same intended use, technology, design and performance specifications are either identical or substantially equivalent to existing legally marketed predicate devices. The differences between the Sterile Auto-Disable syringes with/without needle for single use and predicate devices do not alter suitability of the proposed device for its intended use.

Device feature	Subject Device	Predicate Device K143497	Comment
Indications foruse	The Sterile Auto-Disablesyringes with/without needlefor single use is used foraspiration of fluids from vialsand ampoules and a variety offluid injections below thesurface of the skin exceptphlebotomy.	The Safety Auto-DisableSyringe with Needle(Auto-Lock) is used foraspiration of fluids from vialsand ampoules and a variety offluid injections below thesurface of the skin exceptphlebotomy.It has a detachable needle witha dedicated fitting. The SafetyAuto-Disabled Syringe withNeedle (Auto-Lock) contains aninner mechanism used to allowthe needle to be retractedinside the plunger rod of thesyringe after the operator'sthumb force released. Afteractivation the needle is fullycontained inside the syringe	DifferentComment #1

Table 5-1 Substantial equivalence discussion – Sterile Auto-Disable syringes with/without

needle for single use
Device feature	Subject Device	Predicate Device K143497	Comment
		guarding against accidentalneedle sticks during normalhandling and disposal of theused needle/syringecombination.
Product code	FMF, FMI	MEG, FMF, FMI	DifferentComment #2
Regulationnumber	21 CFR 880.5860	21 CFR 880.5860	Same
Class	II	II	Same
Principle ofoperation	For manual use only	For manual use only	Same
Safety Features	Active safety feature, manuallyactivated by user	Active safety feature, manuallyactivated by user	Same
Intended user	Medical professionals andtrained care givers	Medical professionals andtrained care givers	Same
Environment ofuse	Hospitals and clinics	Hospitals and clinics	Same
Syringe volume	1 ml, 3 ml, 5 ml, 10 ml	1ml, 3ml, 5ml, 10ml	Same
Nozzle type	Luer slip; Luer lock	Needle hub Luer connector	Same
Lubricant	Silicone oil	PDMS	Same
Barreltransparency	Transparent and clear	Clear as required byISO 7886-1	Same
Gradationslegibility	Legible	Legible according toISO 7886-1	Same
Needle Length	1/2", 5/8", 1", 1 1/4", 1 1/2"	12-38mm	Same
Needle Gauge	18G, 19G, 20G, 21G, 22G,23G, 24G, 25G, 26G, 27G,30G	21G, 22G, 23G, 24G, 25G,26G, 27G, 28G	DifferentComment #3
Configuration ofthe tip	Short bevel, long bevel.	15 °C regular point	DifferentComment #4
Needle hub	Color-coded per ISO 6009	Colorless according to ISO7864	Same
Single use	Yes	Yes	Same
Performancespecifications	Complies with ISO 7864, ISO7886-1, ISO 7886-4	Conforms to ISO 7864, ISO7886-1, ISO 7886-4	Same
Sterilization	EO	EO	Same
SAL	10⁻⁶	10⁻⁶	Same
Materials	Barrel: PP	Barrel: Polypropylene	Different
Device feature	Subject Device	Predicate Device K143497	Comment
	Plunger: PP	Plunger: Polypropylene	Comment #5
	Piston: Silicone Rubber	Piston: Isoprene rubber
	Needle: Stainless steel	Needle Hub: Polypropylene
	Needle hub: PP	Needle: Stainless SteelNeedle Sheath: Stainless SteelO Ring : Silicone rubber
Pyrogen	Non-pyrogenic	Non-pyrogenic	Same
Biocompatibility	Conforms to ISO 10993 Seebelow	Conforms to ISO10993	Same
Labeling	Meet the requirements of 21CFR Part 801	Meet the requirements of 21CFR Part 801	Same

{5}------------------------------------------------

{6}------------------------------------------------

Comment #1

The subject device and the predicate device have the same intended use, to aspirate and inject fluids into a patient. The predicate device has a needle safety feature which after use allows the needle to be encapsulated into the plunger rod of the syringe to prevent needle sticks, thus preventing re-use of the syringe. The subject device does not have a needle safety feature but has a disc on the plunger which could be stuck by the buckle of the syringe to prevent re-use of the syringe. The subject device and the predicate device both have the same intended use, this difference does not affect the clinical safety of the subject device.

Comment #2

The subject device and the predicate device are both syringes that render the syringe unusable after injection, the predicate device also has a needle safety feature.

Comment #3

The subject device is available in gauges 18g-30g and the predicate device is available in 21g-28g. Performance testing was done per ISO 9626 and ISO 7864 done to demonstrate that the differences in needle gauges do not affect the clinical safety or effectiveness of the devices.

Comment #4

The bevel of subject device is different from the predicate device. However, this difference does not affect intended use. The difference was addressed through ISO 9626 and ISO 7864. Therefore, the differences on bevel do not raise different question of safety and effectiveness.

{7}------------------------------------------------

Comment #5

The material of subject device is different from the predicate device. The piston of subject device is silicone rubber while the predicate device is isoprene rubber. And the configurations of subject device do not include Needle Sheath compared with predicate device, which was not affect intended use and did not introduce new materials. However, the materials of subject device were demonstrated by the biocompatibility tests done. Therefore, the differences on materials do not raise new questions about safety and effectiveness.

VII Performance Testing

The following performance data were provided in support of the substantial equivalence determination.

Biocompatibility testing

In accordance with ISO 10993-1, the device is classified as Externally Communicating Device, Blood Path Indirect, Limited Contac (<24 hours). The following tests were conducted:

Cytotoxicity
Skin Sensitization ●
. Intracutaneous Reactivity (Irritation)
Acute Systemic Toxicity ●
Material-Mediated Pyrogens
Hemolysis ●
Particulate Matter per USP <788>

Sterilization, Shipping and shelf-life

. EO sterilization validation per ISO11135:2014
Pyrogen testing per USP <85> Bacterial Endotoxin Test .
EO residuals per ISO 10993-7 ●
Simulated shipping per ASTM D4169 ●
Sterile Barrier Package testing performed on the proposed device: .
- o Seal Strength ASTM F88/F88M-2015
- o Bubble leak testing ASTM D3078-02(2013)
- o Dye Penetration ASTM F1929-2015
Shelf life of 5 years validated using FDA recognized standards ASTM F1980-16 . Standard Guide for Accelerated Aging of sterile barrier Systems for Medical Devices

Performance testing

Performance testing is performed according to the following standards:

ISO 7864:2016 Sterile hypodermic needles for single use Requirements and test A methods

{8}------------------------------------------------

A ISO 9626:2016, Stainless Steel Needle Tubing For The Manufacture of Medical Devices
ISO 80369-7:2016 Small-bore connectors for liquids and gases in healthcare applications — Part 7: Connectors for intravascular or hypodermic applications
ISO 7886-4:2018 sterile hypodermic syringes for single use — part 4: syringes with re-use prevention feature.
A ISO 7886-1:2017 Sterile hypodermic syringes for single use- Part 1: Syringes for manual use.

VIII Conclusion

The differences between the predicate and subject device do not raise any new or different questions of safety or effectiveness. The Sterile Auto-Disable syringes with/without needle for single use are substantially equivalent to The Safety Auto-Disable Syringe with Needle (Auto-Lock) with respect to indications for use, target population, and technological characteristics.

Regulation Number and Section

§ 880.5860 Piston syringe.

(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).